Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 855-863

  Oridate, Nobuhiko ^a   Lotan, Dafna ^a   Xu, Xiao Chun ^a   Hong, Waun K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; PROPIDIUM IODIDE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MORPHOLOGY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FENRETINIDE; HEAD AND NECK NEOPLASMS; HUMANS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029887265     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
3. Lippman, S. M., Banner, S. E., and Hong, W. K. Cancer chemoprevention. J. Clin. Oncol., 12: 851-873, 1994.
4. Lotan, R. Squamous cell differentiation markers in normal, premalignant, and malignant epithelium: effects of retinoids. J. Cell. Biochem., 17(Suppl.): 167-174, 1993.
5. Hong, W., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
6. Costa, A., Formelli, F., Chiesa, F., Decensi, A., De Palo, G., and Veronesi, U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res., 54(Suppl.): 2032s-2037s, 1994.
7. Moon, R. C., Thompson, H. J., Becci, P. J., Grubbs, C. J., Gander, R. J., Newton, D. L., Smith, J. M., Phillips, S. L., Henderson, W. R., Mullen, L. T., Brown, C. C., and Sporn, M. B. N-(4-Hydroxyphenyl)-retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39: 1339-1346, 1979.
8. Moon, R. C., and Mehta, R. G. Chemoprevention of experimental carcinogenesis in animals. Prev. Med., 18: 576-591, 1989.
9. Ratko, T. A., Detrisac, C. J., Dinger, N. M., Thomas, C. F., Kelloff, G. I., and Moon, R. C. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Cancer Res., 49: 4472-4476, 1989.
10. Moon, R. C., Pritchard, J. F., Mehta, R. G., Nomides, C. T., Thomas, C. F., and Dinger, N. M. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Carcinogenesis (Lond.), 10: 1645-1649, 1989.
11. Steele, V. E., Kelloff, G. J., Wilkinson, B. P., and Arnold, J. T. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res., 50: 2068-2074, 1990.
12. Pollard, M., Luckert, P. H., and Sporn, M. B. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51: 3610-3611, 1991.
13. Dowlatshahi, K., Mehta, R. G., Thomas, C. F., Dinger, N. M., and Moon, R. C. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer. Cancer Lett., 47: 187-192, 1989.
14. Pienta, K. J., Nguyen, N. M., and Lehr, J. E. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res., 53: 224-226, 1993.
15. Formelli, F., and Cleris, L. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res., 53: 5374-5376, 1993.
16. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Clerici, M., Formelli, F., Barzan, L., Carrassi, A., Pastorini, A., Camerini, T., Clerici, M., Formelli, F., Giardini, R., Minn, F. L., Zurrida, S., Costa, A., de Palo, G., and Veronesi, U. Chemoprevention of recurrences and new localisations in patients operated for oral leukoplakia with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Oral Oncol. Eur. J. Cancer B, 28B: 97-102, 1992.
17. Chiesa, F., Tradati, N., Marazza, M., Rossi, N., Boracchi, P., Mariani, L., Formelli, F., Giardini, R., Costa, A., De Palo, G., and Veronesi, U. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J. Cell. Biochem., 17F(Suppl.): 255-261, 1993.
18. Tradati, N., Chiesa, F., Rossi, N., Grigolato, R., Formelli, F., Costa, A., and de Palo, G. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett., 76: 109-111, 1994.
19. De Palo, G., Veronesi, U., Camerini, T., Formelli, F., Mascotti, G., Boni, C., Fosser, V., Del Vecchio, M., Campa, T., Costa, A., and Marubini, E. Can fenretinide protect women against ovarian cancer? J. Natl. Cancer Inst., 87: 146-147, 1995.
20. Decensi, A., Formelli, F., Torrisi, R., and Costa, A. Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpoints. J. Cell Biochem., 17G(Suppl.): 226-233, 1993.
21. Greenwald, P., Kelloff, G., Burch-Whitman, C., and Kramer, B. S. Chemoprevention. CA Cancer J. Clin., 45: 31-49, 1995.
22. Meyskens, F. L., Jr., Alberts, D. S., and Salmon, S. E. Effect of 13-cis-Retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar. Int. J. Cancer, 32: 295-299, 1983.
23. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grignani, F., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U., and Pierotti, M. A N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res., 53: 6036-6041, 1993.
24. Mariotti, A., Marcora, E., Bunone, G., Costa, A., Veronesi, U., Pierotti, M. A., and Della Valle, G. N-(4-Hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst., 86: 1245-1247, 1994.
25. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistola, V., Raffaghello, L., Rozz, C., and Montaldo, P. G. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res., 55: 853-861, 1995.
26. Martin, S., Bradley, J. G., and Cotter, T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
27. Anzai, N., Kawabata, H., Hirama, T., Masutani, H., Ohmori, M., Yoshida, Y., and Okuma, M. Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation. Leukemia (Basingstoke), 8: 446-453, 1994.
28. Piacentini, M., Annicchiarico-Petruzzelli, M., Oliverio, S., Piredda, L. Biedler, J. I., and Melino, E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer, 52: 271-278, 1992.
29. Jiang, H., and Kochhar, D. M. Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology, 46: 333-340, 1992.
30. Piacentini, M., Fesus, L., Farrace, M. G., Ghibelli, L., Piredda, L., and Melino, G. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur. J. Cell Biol., 54: 246-254, 1991.
31. Suedhoff, T., Birckbichler, P. J., Lee, K. N., Conway, E., and Patterson, M. K. J. Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid. Cancer Res., 50: 7830-7834, 1990.
32. Davies, P. J. A., Stein, J. P., Chiocca, E. A. Basilion, L. P., Gentile, V., Thomazy, V., and Fesus, L. Retinoid-regulated expression of transglutaminases: links to the biochemistry of programmed cell death. In: G. Morriss-Kay (ed.). Retinoids in Normal Development and Teratogenesis, pp. 249-263. Oxford, England: Oxford University Press, 1992.
33. Chomienne, C., Barbey, S., Balitrand, N., Degos, L., and Sachs, L. Regulation of Bcl-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells (Abstract). Proc. Am. Assoc. Cancer Res., 33: 41, 1992.
34. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
35. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
36. Carey, T. E., Van Dyke, D. L., Worsham, M. J., Bradford, C. R., Babu, V. R., Schwartz, D. R., Hsu, S., and Baker, S. R. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res., 49: 6098-6107, 1989.
37. Krause, C. I., Carey, T. E., Ott, R. W., Hurbis, C., McClatchey, K. D., and Regezi, J. A. Human squamous cell carcinoma, establishment and characterization of new permanent cell lines. Arch. Ototaryngol., 107: 703-710, 1981.
38. Sprik, S. A., Sullivan, M. J., and Carey, T. E. In vitro photosensitization of human head and neck squamous cancer cells by dihematoporphyrin-ether. Otolaryngol. Head Neck Surg., 99: 28-37, 1988.
39. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48: 2858-2866, 1988.
40. Reiss, M., Pitman, S. W., and Sartorelli, A. C. Modulation of the terminal differentiation of human squamous carcinoma cells in vitro by all-trans-retinoic acid. J. Natl. Cancer Inst., 74: 1015-1023, 1985.
41. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R. Apoptotic cell death induced by c-myc is inhibited by bcl-1. Nature (Lond.), 559: 552-554, 1992.
42. Jacobson, M. D., Burne, J. R, King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 361: 365-369, 1993.
43. Robinson, G., and Gray, T. Electron microscopy 2: tissue preparation, sectioning and staining. In: J. D. Bancroft, A. Stevens, and D. R. Turner (eds.), Theory and Practice of Histological Techniques, pp. 525-562. Edinburgh: Churchill Livingstone, 1990.
44. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.), 284: 555-556, 1980.
45. Ucker, D. S., Obermiller, P. S., Eckhan, W., Apgar, J. R., Berger, N. A. and Meyers, J. Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol., 12: 3060-3069, 1992.
46. Cohen, G. M., Sun, X. M., Snowden, R. T, Dinsdale, D., and Skilleter, D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J., 286: 331-334, 1992.
47. Tomei, L. D., Shapiro, J. P., and Cope, F. O. Apoptosis in C3H/ 10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc. Natl. Acad. Sci. USA, 90: 853-857, 1993.
48. Zakeri, Z. F., Quaglino, D., Latham, T., and Lockshin, R. A. Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J., 7: 470-478, 1993.
49. Oberhammer, F., Fritsch, G., Schmied, M., Pavelka, M., Printz, D., Purchio, T., Lassmann, H., and Schulte-Hermann, R. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci., 104: 317-326, 1993.
50. Fukuda, K., Kojiro, M., and Chiu, J. F. Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis? Am. J. Pathol., 142: 935-946, 1993.
51. 2+)-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol. Appl. Pharmacol., 112: 32-40, 1992.
52. Harrington, E. A., Fanidi, A., and Evan, G. I. Oncogenes and cell death. Curr. Opin. Genet. Dev., 4: 120-129, 1994.
53. Haake, A. R., and Polakovska, R. R. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol., 101: 107-112, 1993.
54. Thompson, H. J., Strange, R., and Schedin, P. J. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prev., 1: 597-602, 1992.
55. Amos, B., and Lotan, R. Retinoid sensitive cells and cell lines. Methods Enzymol., 190: 217-225, 1991.
56. Sacks, P. G., Oke, V., Calkins, D. P., Vasey, T., and Terry, N. H. A. Effects of β-all-trans-retinoic acid on growth, proliferation, and cell death in a multicellular tumor spheroid model for squamous carcinomas. J. Cell. Physiol., 144: 237-243, 1990.
57. Kochhar, D. M., Jiang, H., Harnish, D. C., and Soprano, D. R. Evidence that retinoic acid-induced apoptosis in the mouse limb bud core mesenchymal cells is gene-mediated. Prog. Clin. Biol. Res., 383B: 815-825, 1993.
58. Lotan, R., and Clifford, J. L. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed. Pharmacother., 45: 145-156, 1994.
59. Mangelsdorf, D. J., Umesono, K., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 319-349. New York: Raven Press, 1994.
60. Chambon, P. The retinoid signalling pathway: molecular and genetic analyses. Semin. Cell Biol., 5: 115-125, 1994.
61. Zou, C., Clifford, J. L., Xu, X.-C., Sacks, P. G., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid of squamous cell differentiation, cellular RA-bindmg proteins, and nuclear RA receptors in human head and neck squamous carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
62. Xu, X-C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K., and Lotan, R. Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res., 54: 3580-3587, 1994.
63. Dive, C., and Wyllie, A. H. Apoptosis and cancer chemotherapy. In: J. A. Hickman and T. T Tritton (eds.), Frontiers in Pharmacology: Cancer Chemotherapy, pp. 21-56. Oxford: Blackwell Scientific Publications, Ltd., 1993.
64. Formelli, F., Clerici, M., Campa, T., Di Mauro, M. G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., Costa, A., and Veronesi, U. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol., 11: 2036-2042, 1993.